Abstract
Chemical exchange saturation transfer (CEST) offers many advantages as a method of generating contrast in magnetic resonance images. However, many of the exogenous agents currently under investigation suffer from detection limits that are still somewhat short of what can be achieved with more traditional Gd3+ agents. To remedy this limitation we have undertaken an investigation of Ln3+ DOTA-tetraamide chelates (where DOTA is 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) that have unusually rigid ligand structures: the nitrobenzyl derivatives of DOTA-tetraamides with (2-phenylethyl)amide substituents. In this report we examine the effect of incorporating hydrophobic amide substituents on water exchange and CEST. The ligand systems chosen afforded a total of three CEST-active isomeric square antiprismatic chelates; each of these chelates was found to have different water exchange and CEST characteristics. The position of a nitrobenzyl substituent on the macrocyclic ring strongly influenced the way in which the chelate and Ln3+ coordination cage distorted. These differential distortions were found to affect the rate of water proton exchange in the chelates. But, by far the greatest effect arose from altering the position of the hydrophobic amide substituent, which, when forced upwards around the water binding site, caused a substantial reduction in the rate of water proton exchange. Such slow water proton exchange afforded a chelate that was 4.5 times more effective as a CEST agent than its isomeric counterparts in dry acetonitrile and at low temperatures and very low presaturation powers.
This is a preview of subscription content, access via your institution.













References
Zhang S, Winter P, Wu K, Sherry AD (2001) J Am Chem Soc 123:1517–1518
Sherry AD, Zhang S, Woods M (2005) In: Sessler JL, Doctrow SR, McMurray TJ, Lippard SJ, (eds) Medicinal inorganic chemistry. ACS symposium series 903. American Chemical Society, Washington, pp 151–165
Ward KM, Aletras AH, Balaban RS (2000) J Magn Reson 143:79–87
Bonnet CS, Toth E (2010) Am J Neuroradiol 31:401–409
Dorazio SJ, Morrow JR (2012) Eur J Inorg Chem 2012:2006–2014
Gianolio E, Stefania R, Di Gregorio E, Aime S (2012) Eur J Inorg Chem 2012:1934–1944
Hancu I, Dixon WT, Woods M, Vinogradov E, Sherry AD, Lenkinski RE (2010) Acta Radiol 51:910–923
Pacheco-Torres J, Calle D, Lizarbe B, Negri V, Ubide C, Fayos R, Larrubia Pilar L, Ballesteros P, Cerdan S (2011) Curr Top Med Chem 11:115–130
Sherry AD, Woods M (2007) In: Modo MMJ, Bulte JWM (eds) Molecular and cellular MR imaging. CRC, Boca Raton, pp 101–122
Terreno E, Delli Castelli D, Aime S (2010) Contrast Media Mol Imaging 5:78–98
Tsitovich PB, Morrow JR (2012) Inorg Chim Acta 393:3–11
Viswanathan S, Kovacs Z, Green KN, Ratnakar SJ, Sherry AD (2010) Chem Rev 110:2960–3018
Winter PM (2012) Wiley Interdiscip Rev Nanomed Nanobiotechnol 4:389–398
Woods M, Woessner DE, Sherry AD (2006) Chem Soc Rev 35:500–511
Ali MM, Bhuiyan MPI, Janic B, Varma NRS, Mikkelsen T, Ewing JR, Knight RA, Pagel MD, Arbab AS (2012) Nanomedicine 7:1827–1837
Ali MM, Yoo B, Pagel MD (2009) Mol Pharm 6:1409–1416
Ferrauto G, Delli Castelli D, Terreno E, Aime S (2013) Magn Reson Med 69:1703–1711
Li AX, Suchy M, Li C, Gati JS, Meakin S, Hudson RHE, Menon RS, Bartha R (2011) Magn Reson Med 66:67–72
Liu G, Li Y, Shethy VR, Pagel MD (2012) Mol Imaging 11:47–57
Sheth VR, Li Y, Chen LQ, Howison CM, Flask CA, Pagel MD (2012) Magn Reson Med 67:760–768
Yoo B, Sheth VR, Howison CM, Douglas MJK, Pineda CT, Maine EA, Baker AF, Pagel MD (2013) Magn Reson Med. doi:10.1002/mrm.24763.
Carney CE, Tran AD, Wang J, Schabel MC, Sherry AD, Woods M (2011) Chem Eur J 17:10372–10378
Woods M, Kovacs Z, Zhang S, Sherry AD (2003) Angew Chem Int Ed 42:5889–5892
Woods M, Botta M, Avedano S, Wang J, Sherry AD (2005) Dalton Trans 3829–3837
Di Bari L, Pescitelli G, Sherry AD, Woods M (2005) Inorg Chem 44:8391–8398
Tircso G, Webber BC, Kucera BE, Young VG, Woods M (2011) Inorg Chem 50:7966–7979
Webber BC, Woods M (2012) Inorg Chem 51:8576–8582
Graham B, Loh CT, Swarbrick JD, Ung P, Shin J, Yagi H, Jia X, Chhabra S, Barlow N, Pintacuda G, Huber T, Otting G (2011) Bioconjug Chem 22:2118–2125
Ranganathan RS, Raju N, Fan H, Zhang X, Tweedle MF, Desreux JF, Jacques V (2002) Inorg Chem 41:6856–6866
Baranyai Z, Banyai I, Brucher E, Kiraly R, Terreno E (2007) Eur J Inorg Chem 2007:3639–3645
Thompson AL, Parker D, Fulton DA, Howard JAK, Pandya SU, Puschmann H, Senanayake K, Stenson PA, Badari A, Botta M, Avedano S, Aime S (2006) Dalton Trans 5605–5616
Miller KJ, Saherwala AA, Webber BC, Wu Y, Sherry AD, Woods M (2010) Inorg Chem 49:8662–8664
Woods M, Pasha A, Zhao P, Tircso G, Chowdhury S, Kiefer G, Woessner DE, Sherry AD (2011) Dalton Trans 40:6759–6764
Dickins RS, Parker D, Bruce JI, Tozer DJ (2003) Dalton Trans 1264–1271
Thompson AL, Parker D, Fulton DA, Howard JAK, Pandya SU, Puschmann H, Senanayake K, Stenson PA, Badari A, Botta M, Avedano S, Aime S (2006) Dalton Trans 5605–5616
Frias JC, Bobba G, Cann MJ, Hutchison CJ, Parker D (2003) Org Biomol Chem 1:905–907
Parker D, Dickins RS, Puschmann H, Crossland C, Howard JAK (2002) Chem Rev 102:1977–2010
Aime S, Barge A, Batsanov AS, Botta M, Castelli DD, Fedeli F, Mortillaro A, Parker D, Puschmann H (2002) Chem Commun 1120–1121
Woods M, Zhang S, Von Howard E, Sherry AD (2003) Chem Eur J 9:4634–4640
Meyer M, Dahaoui-Gindrey V, Lecomte C, Guilard L (1998) Coord Chem Rev 180:1313–1405
Aime S, Botta M, Ermondi G, Terreno E, Anelli PL, Fedeli F, Uggeri F (1996) Inorg Chem 35:2726–2736
Adair C, Woods M, Zhao PY, Pasha A, Winters PM, Lanza GM, Athey P, Sherry AD, Kiefer GE (2007) Contrast Media Mol Imaging 2:55–58
Woods M, Kovacs Z, Kiraly R, Brücher E, Zhang S, Sherry AD (2004) Inorg Chem 43:2845–2851
Marques MPM, Geraldes CFGC, Sherry AD, Merbach AE, Powell H, Pubanz D, Aime S, Botta M (1995) J Alloys Compd 225:303–307
Karplus M (1963) J Am Chem Soc 85:2870–2871
Aime S, Botta M, Ermondi G (1992) Inorg Chem 31:4291–4299
Aime S, Botta M, Fasano M, Marques MPM, Geraldes CFGC, Pubanz D, Merbach AE (1997) Inorg Chem 36:2059–2068
Vipond J, Woods M, Zhao P, Tircso G, Ren JM, Bott SG, Ogrin D, Kiefer GE, Kovacs Z, Sherry AD (2007) Inorg Chem 46:2584–2595
Aime S, Botta M, Garda Z, Kucera BE, Tircso G, Young VG, Woods M (2011) Inorg Chem 50:7955–7965
Woessner DE, Zhang S, Merritt ME, Sherry AD (2005) Magn Reson Med 53:790–799
Dixon WT, Ren J, Lubag AJM, Ratnakar J, Vinogradov E, Hancu I, Lenkinski RE, Sherry AD (2010) Magn Reson Med 63:625–632
Woods M, Caravan P, Geraldes CFGC, Greenfield MT, Kiefer GE, Lin M, McMillan K, Prata MIM, Santos AC, Sun X, Wang J, Zhang S, Zhao P, Sherry AD (2008) Invest Radiol 43:861–870
Acknowledgments
The authors thank the National Institutes of Health (EB-11687), the Oregon Nanoscience and Microtechnologies Institute (N00014-11-1-0193), Portland State University, and the Oregon Opportunity for Biomedical Research for financial support of this work.
Author information
Authors and Affiliations
Corresponding author
Additional information
Responsible editor: Valerie C. Pierre.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Slack, J.R., Woods, M. The effect of regioisomerism on the coordination chemistry and CEST properties of lanthanide(III) NB-DOTA-tetraamide chelates. J Biol Inorg Chem 19, 173–189 (2014). https://doi.org/10.1007/s00775-013-1060-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-013-1060-y
Keywords
- Conformational control
- Lanthanide chelates
- Macrocyclic ligands
- Paramagnetic chemical exchange saturation transfer agents
- Stereoisomerism